Pegging The Value Of NKTR-214 At Zero [Seeking Alpha]
Nektar Therapeutics (NKTR)
Last nektar therapeutics earnings: 2/27 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nektar.com/investor-relations
Company Research
Source: Seeking Alpha
Summary Please see the accompanying Slide Deck . A full PDF version of this article is provided at the bottom of this article. Since mid-2017, Nektar Therapeutics' ( NKTR ) stock price has tripled based on the view that its flagship clinical-stage drug NKTR-214 is a promising treatment for cancer, particularly in combination with checkpoint inhibitors. NKTR-214 is a pegylated form of recombinant IL-2, a naturally occurring cytokine that was first discovered in 1976 and approved for treating cancer in 1992 . By binding with the IL2Rß? receptor, IL-2 stimulates proliferation of cytotoxic lymphocytes, which then attack cancer cells. However, IL-2 has a short half-life and also binds with the IL2Raß? receptor, which is thought to induce proliferation of immunosuppressive Treg cells. Nektar hypothesized that IL-2 could be improved by adding polyethylene glycol molecules to it (pegylating it) to extend the half-life and block interaction with IL2Raß?. Unfortunately, t
Show less
Read more
Impact Snapshot
Event Time:
NKTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NKTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NKTR alerts
High impacting Nektar Therapeutics news events
Weekly update
A roundup of the hottest topics
NKTR
News
- Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]Yahoo! Finance
- Nektar Therapeutics Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Nektar Therapeutics Reports First Quarter 2024 Financial ResultsPR Newswire
- Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets [Yahoo! Finance]Yahoo! Finance
NKTR
Earnings
- 5/9/24 - Beat
NKTR
Sec Filings
- 5/10/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/26/24 - Form ARS
- NKTR's page on the SEC website